News

Biopharmaceutical laboratories working across R&D, manufacturing and quality control (QC) environments can now streamline biopharmaceutical characterization, process monitoring and release testing using a new seamless, built-for-purpose multi-attribute method (MAM) workflow. The Thermo Scientific MAM 2.0 workflow is a culmination of...

Australia on Wednesday authorised booster shots of Covid-19 vaccines for over-18s, with the third dose expected to be offered to the entire population from next month. The Therapeutic Goods Administration regulatory authority said it had granted provisional approval for one...

The Health Ministry of Russia has reportedly granted approval for administering Covid-19 vaccine Sputnik V and flu shots simultaneously, making changes to the instruction for the vaccine use. Studies have demonstrated that the joint administration of both vaccines has not...

BioNTech SE announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022. This is the next step in BioNTech’s efforts to implement sustainable end-to-end vaccine...

Abzena, the leading Partner Research Organization (PRO) for outsourced solutions integrating gene to commercial for large molecules and bioconjugates, announced it has promoted Dr. Louise Duffy as Chief Technical Officer. Reporting to Kimball Hall, President and Chief Operating Officer, and...

Backed by 300 years of combined cellulosic excipient experience, including leading brands like Avicel® and METHOCEL™, a robust seaweed-based excipient portfolio and deep technical expertise, IFF’s Pharma Solutions will reaffirm its commitment to helping customers globally deliver consistent, high-quality...

HistoWiz, a leading digital histopathology service company, announced the closing of its $32 million Series A financing. The company has provided automated histology for over 1000 customers in academia and industry and built PathologyMapTM, an intelligent tissue platform that...